Patent · US Active

RNAs for wound healing

US11542490B2 · kind B2 · utility

7Cited by

0References

20Claims

0Family size

Assignee

CureVac SE · DE

Inventors

Nigel HORSCROFT · Tübingen, DE
Marion PÖNISCH · Tübingen, DE
Christine WEINL-TENBRUCK · Tübingen, DE

Key dates

Filing date	Dec 8, 2017
Grant date	Jan 3, 2023
Priority date	—
Expiry date	Oct 3, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an RNA encoding a therapeutic protein, in particular a collagenase, growth factor, cytokine, receptor, chaperone or signal transduction inhibitor. In particular, the present invention relates to RNA suitable for treatment of wounds, specifically for promoting wound healing. The present invention concerns such RNA as well as pharmaceutical compositions and kits and combinations comprising the RNA. Furthermore, the present invention relates to the RNA, pharmaceutical compositions, kits as disclosed herein for use in the treatment of wounds, specifically for promoting wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.